Melanie provides pragmatic and experienced counsel to public and private companies in a broad range of matters, including initial public offerings and other capital market transactions, fallen angel reverse mergers, corporate governance, public company reporting, mergers and acquisitions and other corporate transactional matters.
She regularly represents issuers and financing sources in the medical devices, life sciences and healthcare services industries.
Before joining Mintz, Melanie worked as a health care and science division legal associate for Thomson Reuters. In this position, she collaborated directly with data engineers and technology specialists in the design and implementation of solutions in response to the legislative and regulatory changes implemented by the Obama administration regarding health information exchanges, electronic medical records, and healthcare provider reporting and quality measures.
Experience
- Represented life sciences companies in initial public offerings
- Represented Evofem Biosciences, Inc. in its reverse merger with Neothetics, Inc.
- Represented Mateon Therapeutics, Inc. in its reverse merger with Oncotelic, Inc.
- Represented Dare Bioscience, Inc. in its reverse merger with Cerulean Pharma Inc.
- Represented MabVax Therapeutics, Inc. in its reverse merger with Telik, Inc.
- Represented software company in merger transaction with public company
- Represented medical device company in cross border asset acquisition transaction with a Fortune 500 company
- Represented medical device company in merger with Fortune 500 company
- Represented medical software company in sale to large public software company
- Represented professional services company in acquisition by private equity fund
- Represented real estate finance company in merger with private company
- Represented financial technology software company in multiple rounds of venture backed private placements
- Represented medical device company in multiple venture backed private placements
- Assisted numerous public life sciences companies in private and public follow on offerings
- Represented venture fund in transactions with private battery and technology companies
- Represented private semi-conductor company in multiple venture backed and private placement funding rounds
viewpoints
From the Edge - In the Boardroom: Session 1 - Board Basics
September 7, 2022 | Podcast | By Thomas Burton, Melanie Ruthrauff Levy, Stephen Osborn
Welcome to our new podcast series In the Boardroom: Practical Advice and Guidance, featuring insights from Mintz Members Steve Osborn, Melanie Levy, and Tom Burton on a wide variety of topics specific to boards. They’ll answer all of your questions related to the “who, what, when, where, and how” of boards.
Read more
California Board Diversity Statute Unconstitutional
April 12, 2022 | Alert | By Kevin M. Yao, Melanie Ruthrauff Levy
Preparation for 2021 Fiscal Year-End SEC Filings and 2022 Annual Shareholder Meetings
January 18, 2022 | Advisory | By Megan Gates, John Condon, Anne Bruno, Melanie Ruthrauff Levy, Daniel T. Kajunski, Cynthia Larose, Breton Leone-Quick, Page R. Hubben
Read about key regulatory and other developments, including board diversity and other ESG matters, which public companies need to consider as they prepare for their fiscal year-end SEC filings and 2022 annual shareholder meetings.
Read more
Two Recent SEC No Action Letters Establish Standards for Crowdsourcing Online Platforms Limited to "Accredited Investors" to Avoid Registration as a Broker-Dealer
April 3, 2018 | Alert | By Daniel DeWolf, Jeremy Glaser, Steve Ganis, Melanie Ruthrauff Levy
In two recent no action letters, the Securities and Exchange Commission (the “SEC”) granted no action relief for two venture capital online funding platforms, the FundersClub, Inc. (“FundersClub”) and AngelList, LLC (“AngelList”), allowing them to avoid registering as broker-dealers under the Securities Exchange Act of 1934 (the “Exchange Act”) even though their affiliates will receive some compensation in the form of a carried interest.
Read more
News & Press
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
Mintz Debuts 'Femtech' Practice For Life Science Clients
March 9, 2023
Law360 featured the launch of the firm's Women's Health and Technology practice and highlighted founding Members Ellen Janos, Joanne Hawana, Karen Lovitch, and Melanie Levy.
Mintz Forms Pioneering Women’s Health & Technology Practice
March 09, 2023
BOSTON – Mintz has launched a Women’s Health and Technology practice, bringing together attorneys from across the firm’s transactional, intellectual property, health care and FDA regulatory, and litigation teams with a focus on serving clients in life sciences, specifically FemTech.
Mintz Announces Nine Newly Elevated Members
December 17, 2020
Mintz Represents Bio-Medical Devices, Inc. in Sale of SteriShield Manufacturing Operations to Stryker Corporation
September 19, 2016
Mintz lawyers represented Bio-Medical Devices, Inc. in the sale of a section of its manufacturing operations to Stryker Corporation, one of the world’s leading medical technology companies.
Mintz Represents Workterra in Sale to CareerBuilder
September 15, 2016
Attorneys from Mintz represented Workterra, a leading innovator in cloud-based benefits administration and talent management, in its sale to CareerBuilder. The purchase will significantly expand CareerBuilder’s product offering.
Events & Speaking
Recognition & Awards
Best Lawyers of America Ones to Watch - Corporate Law (2021 - 2024)
State Bar of California Wiley W. Manuel Award, Pro Bono Legal Services
San Diego Volunteer Lawyer Program Distinguished Service Award
Order of the Coif
Recent Insights
Preparation for 2023 Fiscal Year-End SEC Filings and 2024 Annual Shareholder Meetings
December 15, 2023| Advisory|
Mintz is pleased to announce that 120 firm attorneys have been recognized as leaders by Best Lawyers® in the 2024 edition of The Best Lawyers in America©.
From the Edge - In the Boardroom: Special Edition - Lessons Learned from Silicon Valley Bank
April 24, 2023| Podcast|
